| 介绍卒中相关炎性生化标志物的种类及其在卒中早期诊断、出血转化、病情预后及复发中的作用。 Kernagis DN, Laskowitz DT. Evolving role of biomarkers in acute cerebrovascular disease[J]. Ann Neurol, 2012, 71:289-303. Roudbary SA, Saadat F, Forghanparast K, et al. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke[J]. Acta Med Iran, 2011, 49:149-152. Di Napoli M, Godoy DA, Campi V, et al. C-reactive protein in intracerebral hemorrhage:time course,tissue localization, and prognosis[J]. Neurology, 2012,79:690-699. Foerch C, Niessner M, Back T, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke[J].Clin Chem, 2012, 58:237-245. Dvorak F, Haberer I, Sitzer M, et al. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke[J]. Cerebrovasc Dis, 2009, 27:37-41. Kavalci C, Genchallac H, Durukan P, et al. Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke[J]. Bratisl Lek Listy, 2011, 112:398-401. Ka t a n M, El k i n d MS . I n f l amma t o r y a n d neuroendocr ine biomarkers of prognosis af ter ischemic stroke[J]. Expert Rev Neurother, 2011,11:225-239. Tut tolomondo A, Di Sciacca R, Di Raimondo D, et al. Pla sma levels of inf lammator y and thrombotic/fibrinolytic markers in acute ischemic strokes:relationship with TOAST subtype, outcome and infarct site[J]. J Neuroimmunol, 2009, 215:84-89. Supanc V, Biloglav Z, Kes VB, et al. Role of cell adhesion molecules in acute ischemic stroke[J]. Ann Saudi Med, 2011, 31:365-370. Luo Y, Wang Z, Li J, et al. Serum CRP concentrations and severity of ischemic stroke subtypes[J]. Can J Neurol Sci, 2012, 39:69-73. Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis,differentiation, and treatment[J]. Clin Chem, 2010,56:21-33. Gorelick PB. Lipoprotein-associated phospholipase A2 and r isk of st roke[J]. Am J Cardiol, 2008,101(12A):34F-40F. Dewan KR, Rana PV. C-reactive protein and early mortality in acute ischemic stroke[J]. Kathmandu Univ Med J, 2011, 9:252-255. Corso G, Bottacchi E, Brusa A, et al. Is there a prognostic role for C-reactive protein in ischemic stroke?[J]. Acta Neurol Scand, 2010, 122:209-216. Song IU, Kim YD, Kim JS, et al. Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke?[J]. Eur Neurol, 2010, 64:304-310. Cojocaru IM, Cojocaru M, Tanasescu R, et al.Expression of IL-6 activity in patients with acute ischemic stroke[J]. Rom J Intern Med, 2009, 47:393-396. Rodriguez-Yanez M, Sobrino T, Arias S, et al. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke[J]. Stroke, 2011, 42:2813-2818. Smedbakken L, Jensen JK, Hallen J, et al. Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke[J]. Stroke, 2011, 42:2453-2458. Welsh P, Lowe GD, Chalmers J, et al. Associations of proinflammatory cytokines with the risk of recurrent stroke[J]. Stroke, 2008, 39:2226-2230. Castillo J, Alvarez-Sabin J, Martinez-Vila E, et al.Inflammation markers and prediction of post-stroke vascular disease recurrence:the MITICO study[J]. J Neurol, 2009, 256:217-224. |
